Back
Roche Holding AG Vs. Novo Nordisk AS Industry Stock Comparison
Sell
48
RHHBY
Roche Holding AG
Last Price:
39.12
Seasonality Move:
2.64%
Sell
49
NVO
Novo Nordisk AS
Last Price:
137.07
Seasonality Move:
4.25%
Sell
48
Roche Holding AG (RHHBY)
is a Sell
Is Roche Holding AG a Buy, Sell or Hold?
- The current Roche Holding AG [RHHBY] share price is $39.11. The Score for RHHBY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- RHHBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $137.00. The Score for NVO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RHHBY Stock Price Chart
What is Roche Holding AG's stock price today?
-
The Roche Holding AG share price today is $39.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHHBY is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $137.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
RHHBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 44.37 | Sell |
| Chaikin Money Flow: | -1086970 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.5 - 41.82) | Sell |
| Bollinger Bands (100): | (31.9 - 39.98) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 54.97 | Buy |
| Chaikin Money Flow: | -388240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.34 - 137.16) | Buy |
| Bollinger Bands (100): | (128.88 - 140.7) | Buy |
RHHBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.51 | Sell |
| 20-day SMA: | 40.74 | Sell |
| 50-day SMA: | 39.42 | Sell |
| 200-day SMA: | 34.84 | Buy |
| 8-day EMA: | 39.44 | Sell |
| 20-day EMA: | 40.07 | Sell |
| 50-day EMA: | 39.1 | Buy |
| 200-day EMA: | 36.09 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.39 | Buy |
| 20-day SMA: | 134.99 | Buy |
| 50-day SMA: | 134.09 | Buy |
| 200-day SMA: | 125.23 | Buy |
| 8-day EMA: | 134.69 | Buy |
| 20-day EMA: | 134.34 | Buy |
| 50-day EMA: | 134.33 | Buy |
| 200-day EMA: | 124.49 | Buy |
Roche Holding AG Earnings Growth & RHHBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.92 per share.
Roche Holding AG Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||